Atlas Trials

Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Clinical trial NCT02278783 · TERMINATED

Trial details

NCT number
NCT02278783
Sponsor
University of Utah
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Start date
2015-03-01
Primary completion
2016-07-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.